摘要
根据冠心病合并心房颤动(房颤)患者缺血和出血的风险评估,制定个体化抗栓策略至关重要。房颤合并急性冠状动脉综合征或冠状动脉介入术后需3联抗栓治疗。长期持续的抗栓治疗策略还取决于患者临床情况、支架种类、抗栓药物类型等。合理选择手术路径、抗栓药物、支架种类以及有效的临床监测和质子泵抑制剂可以明显降低患者的临床风险。
Summary According to the risk assessment of ischemia and hemorrhage for coronary artery disease patients complicated with atrial fibrillation（AF）,formulating individual strategy of antithrombus is very important.Triple antithrombotic therapy should be administrated to AF patients complicated with acute coronary syndrome or undergoing percutaneous coronary intervention（PCI）.The long-term antithrombotic strategy also depends on the clinical situation of patients,stent type,antithrombotic drugs selection,and so on.Reasonable choice of vascular access for PCI,antithrombotic drugs,stent type,effective clinical monitoring and proton pump inhibitors can significantly reduce clinical risks of patients.
出处
《临床心血管病杂志》
CAS
CSCD
北大核心
2015年第4期370-373,共4页
Journal of Clinical Cardiology
关键词
冠心病
心房颤动
抗栓
coronary heart disease
atrial fibrillation
antithrombus
